Singapore, Nov. 3 -- QIAGEN has announced that its QIAsprint Connect and QIAseq FX DNA Library Kit will support automated DNA extraction and library preparation for the SG-INSIGHT study, a cohort under Phase III of Singapore's National Precision Medicine (NPM) programme, as part of a consortium led by Singapore-based precision oncology company Lucence alongside Ultima Genomics.

Coordinated by Precision Health Research, Singapore (PRECISE), NPM Phase III expands Singapore's national precision medicine effort to about 450,000 residents-around 10% of the Singapore resident population-with a shift towards enrolling participants who are receiving medical treatment and healthcare services.

Unlike Phase II, which focused on healthy volunteers,...